4.6 Article

Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage

Journal

JOURNAL OF IMMUNOLOGY
Volume 196, Issue 1, Pages 34-38

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1501312

Keywords

-

Categories

Funding

  1. National Institutes of Health [DK097256, DK72564, DK79392, DK61739, DK055679, DK059888]
  2. Crohn's and Colitis Foundation of America

Ask authors/readers for more resources

IL-1 family members are central mediators of host defense. In this article, we show that the novel IL-1 family member IL-36 gamma was expressed during experimental colitis and human inflammatory bowel disease. Germ-free mice failed to induce IL-36 gamma in response to dextran sodium sulfate (DSS)-induced damage, suggesting that gut microbiota are involved in its induction. Surprisingly, IL-36R-deficient (Il1rl2(-/-)) mice exhibited defective recovery following DSS-induced damage and impaired closure of colonic mucosal biopsy wounds, which coincided with impaired neutrophil accumulation in the wound bed. Failure of Il1rl2(-/-) mice to recover from DSS-induced damage was associated with a profound reduction in IL-22 expression, particularly by colonic neutrophils. Defective recovery of Il1rl2(-/-) mice could be rescued by an aryl hydrocarbon receptor agonist, which was sufficient to restore IL-22 expression and promote full recovery from DSS-induced damage. These findings implicate the IL-36/IL-36R axis in the resolution of intestinal mucosal wounds.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available